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Background: Bipolar disorder (BD) and alcohol use disorder (AUD) are two major
independent causes of psychopathology in the general population. The prevalence of
AUD in BD is high. Identifying the clinical and demographic features of patients with BD
who may develop AUD could help with early identification and intervention.
Methods: Data from 238 patients diagnosed with BD were gathered on alcohol use,
social demographics, longitudinal course of BD, clinical features of the most severe
lifetime manic and depressive episodes, comorbid physical diseases, anxiety disorders,
and other substance use disorders.
Results:We found that 74 of 238 BD patients had AUD (67 with alcohol dependence and
7 with alcohol abuse). Bivariate logistic regression analysis and multivariate logistic
regression analysis found that the best predictors of AUD in patients with BD were
being male (OR = 2.086, 95% CI = 1.094–3.979, p = 0.001), younger (OR = 0.965, 95%
CI = 0.935–0.996, p = 0.026), and comorbidity with other unclassified substance
dependence (OR = 10.817, 95% CI = 1.238–94.550, p = 0.031).
Conclusions: Male, younger current age, and having other substance use disorders
were independently associated with AUD.
Keywords: bipolar disorder, alcohol use disorder, comorbidity, sociodemographics, mental healthINTRODUCTION
Bipolar disorder (BD) and alcohol use disorder (AUD) are two independent major causes of
psychopathology in the general population. BD is a mental health disorder that causes periods of
depression and periods of abnormally elevated mood (1). It includes bipolar I disorder (which
represents classic manic depressive disorder), bipolar II disorder (which is typically characterized by
a hypomanic and a depressive episode) and cyclothymic disorder (which is a milder form of bipolarg September 2020 | Volume 11 | Article 5705741
Xia et al. Bipolar and Alcohol Use Disorderdisorder fluctuating between mild depressive and hypomanic
symptoms) (2). BD affects 1–4% of the global population (3–5).
AUD is a broad term for any drinking of alcohol that
results in mental or physical health problems. The disorder is
divided into two types: alcohol abuse and alcohol dependence
(6). Alcohol abuse encompasses a spectrum of unhealthy alcohol
drinking behaviors, ranging from binge drinking to alcohol
dependence. Alcohol dependence is a previous psychiatric
diagnosis in which an individual is physically or psychologically
dependent upon alcohol. Alcohol abuse has been merged
with alcohol dependence into alcohol use disorder in the
DSM-5 (6).
AUD is one of the most common comorbid disorders among
BD patients (7, 8). AUD is highly prevalent in BD patients with a
comorbidity rate ranging from 44 to 62% (3, 9). The comorbidity
of AUD in bipolar I disorder (BD I) is higher than in bipolar II
disorder (BD II). Lifetime AUD ranges from 46 to 58% in BD I
patients, and from 19 to 39% of those with BD II (8, 10). The
comorbidity of BD in individuals initially identified with AUD is
also high (11).
Several studies have reported that the co-occurrence of AUD
and BD is associated with numerous negative consequences
including increased severity of manic and depressive symptoms
(8, 12, 13), slower recovery from mood episodes, suicide
attempts, elevated use of medications and hospitalization, an
increased risk for other psychiatric and physical disorders, social
dysfunction, and poor quality of life (12–20). A systematic review
and meta-analysis showed that comorbid AUD in individuals
with BD are significantly associated with suicide attempts (21).
Despite the fact that AUD and BD are associated, the nature
of the relationship between these two conditions remains
unclear. Previous studies have reported that alcohol has been
used to induce pleasurable feelings (22) or to alleviate negative
affect and psychiatric symptoms in BD (23). However, Carmiol
et al. found that there is a genetic correlation between BD and
AUD after statistically controlling for comorbid anxiety,
suggesting that genetic factors independent of anxiety influence
the risk of BD comorbidity with AUD (24).
The current study aimed to compare a broad range of
demographic and clinical features between BD patients with
and without comorbid AUD in order to identify the
characteristics of patients at a high risk of developing AUD.METHODS
Participants
The current study was a cross-sectional design. Between
February 2006 and November 2013, a convenience sample of
238 successive patients with BD were recruited from the
Depression and Bipolar Clinic of the Black Dog Institute,
which is a not-for-profit facility in Sydney, Australia for the
diagnosis, treatment, and prevention of mood disorders such as
depression and bipolar disorder. Inclusion criteria for BD
patients were a BD diagnosis using the DSM-IV and aged
between 18 and 85 years old. Participation was voluntary and
no eligible patients declined to participate. Patients withFrontiers in Psychiatry | www.frontiersin.org 2comorbid anxiety disorders or other substance abuse or
dependence were included. Those with significant neurological
or non-psychiatric medical problems were excluded. This study
was approved by the Human Research Ethics Committee of
University of New South Wales. Written informed consent was
obtained from all participants.
Procedures
The assessments of participants included interviews with
questionnaires and ratings by psychiatrists and self-reports
completed on a computer.
BD was diagnosed by psychiatrists who had been trained to
use the Structured Clinical Interview for DSM-IV-TR disorders
(SCID-IV, 2002). Comorbid neurotic-axis (using DSM-IV
terminology) disorders and substance abuse disorders over the
previous 12 months in patients with BD were assessed using
CIDI-AUTO (10, 25). Neurotic-axis disorders assessed included
anorexia nervosa, bulimia nervosa, obsessive-compulsive disorder
(OCD), post-traumatic stress disorder (PTSD), agoraphobia, social
phobia, specific phobia, general anxiety disorder (GAD), and
substance abuse disorders included opioids, cannabis, sedatives,
cocaine, amphetamines, hallucinogens, inhalants, and PCP.
Six standard scales were used to assess the severity of current
symptoms and social functioning: Depression, Anxiety, and
Stress Scale (DASS-42) (26); Montgomery-Asberg Depression
Scale (MADRS) (27); Bipolar Depression Rating Scale (BDRS)
(28); Young Mania Rating Scale (YMRS) (29); Social and
Occupational Functioning Assessment Scale (SOFAS) (30);
CORE (31) which assesses specific bipolar depression
symptoms. Professional psychologists used the face-to-face
Composite International Diagnostic Interview (CIDI-AUTO)
(32) to get the details of alcohol use including the age of onset
of alcohol dependence or abuse and the estimated amount of
alcohol per day in last 12 months.
Demographic and general health information was assessed
using a self-report questionnaire developed by the investigators
including: socio-demographic features (age, gender, country of
birth, education, marital status, labor force status, main source of
personal income); physical conditions (cerebrovascular, brain
trauma, epilepsy, thyroid, cardiovascular, hepatic, renal,
hematological, dermatological, skeletal muscular, diabetes).
Patients were also interviewed regarding their family history of
BD or major depressive disorder, and their number of
hospitalizations. The self-report questionnaire was finished by
participants on the computer.Statistical Analyses
Participants were divided into two groups according to the
presence or absence of a comorbid AUD [alcohol abuse (DSM-
IV diagnosis code 305.00) or dependence (DSM-IV diagnosis
code 303.90)], which was the dependent variable in the
current study.
For the independent variables, categorical variables are
presented as percentages, and continuous variables are
presented as mean±standard deviation (SD). The categorical
variables in the demographic and clinical variables between theSeptember 2020 | Volume 11 | Article 570574
Xia et al. Bipolar and Alcohol Use Disordertwo groups were compared using chi-square tests. The
continuous variables were compared by Mann Whitney-U tests
as they were not normally distributed.
As the differences in age and gender between two groups were
significant, odds ratios (ORs) and 95% confidence intervals (CI)
were determined after adjustment for those two variables for
both continuous and categorical comparisons, using binary
logistic regression analysis. A stepwise multivariate logistic
regression analysis of significant bivariate results was then
performed (33). A confidence level of p < 0.05 was used for all
comparisons. Data analyses were performed using SPSS 22.0
for Windows.RESULTS
Of the 238 participants, 74 (31%) had comorbid AUD (67 with
alcohol dependence and 7 with alcohol abuse). The mean
reported age at onset of AUD was 19 years. The mean
reported consumption of alcohol was 7.66 drinks per day in
the 12 months prior to assessment, compared to 1.99 drinks per
day for the remaining non-AUD participants.
Features and Potential Risk Factors of
Bipolar Patients With and Without Alcohol
Use Disorder
In comparisons of the sociodemographic features between two
groups, participants with AUD were more likely to be men (c2 =
3.994, p = 0.046); not currently married (c2 = 7.780, p = 0.020);
employed (c2 = 4.781, P = 0.029); and younger at enrolment (U =
4897.000, p = 0.034). For physical health conditions, participants
with AUD tended to not have thyroid problems (c2 = 6.182, p =
0.013) and not be allergic to medications (c2 = 5.667, p = 0.017).
Additionally, participants with AUD were more likely to: have
rapid cycling BD (c2 = 4.106, P = 0.043); report a younger age of
their first depressive episode (U = 3906.000, p = 0.024); more
episodes of self-harm (U = 808.000, p = 0.028); more estimated
drinks per day in the last year (U = 1589.000, p < 0.001); cannabis
dependence (c2 = 9.384, p = 0.002); other substance dependence
(unclassified, c2 = 11.915, p = 0.001); show symptoms of PTSD
(c2 = 7.545, p = 0.006) (Supplementary Tables 1–4).
Logistic Regression Analysis of Potential
Risk Factors for Bipolar Patients With
Alcohol Use Disorder After Adjusting for
Age and Gender
As the differences in age and gender between two groups were
significant, theywere adjusted in the logistic regression analysis. For
sociodemographic features, participantsweremore likely tobemale
(OR = 2.256, 95% CI = 1.238–4.111, p = 0.008) and separated,
divorced, or widowed marital status (OR = 2.657, 95% CI = 1.137–
6.206, p= 0.024). Theywere two ormore timesmore likely to inflict
self-harm (OR = 3.719, 95%CI = 1.220–11.340, p = 0.021), recently
report irritability in a past major depressive episode (OR = 2.433,
95% CI = 1.128–5.249, p = 0.023) and at a lower age (OR = 0.965,
95% CI = 0.940–0.990, p = 0.006) (Table 1).Frontiers in Psychiatry | www.frontiersin.org 3In the logistic regression analysis of potential risk factors in
comorbidities with substance abuse disorders and anxiety
disorders of bipolar patients, cannabis dependence (OR =
5.252, 95% CI = 1.556–17.720, p = 0.008), other unclassified
substance dependence (OR = 18.900, 95% CI = 2.241–159.381,
p = 0.007), and PTSD (OR = 2.475, 95% CI = 1.195–5.128, p =
0.015) all showed a relationship with the onset of AUD in bipolar
patients (Table 2).
Multivariate Logistic Regression Analysis
of Potential Risk Factors for Bipolar
Patients With Alcohol Use Disorder
The initial stepwise multivariate logistic regression suggested
that number of suicide attempts, and irritability in the most
severe lifetime depressive episode strongly interfered with other
variables due to missing values. So, these two variables were
deleted from the final logistic regression model (33).
Multivariate logistic regression analysis of discrepant factors
(Table 3) demonstrated that being male (OR = 2.086, 95% CI =
1.094–3.979, p = 0.001), younger current age (OR = 0.965, 95%
CI = 0.935–0.996, p = 0.026), and comorbidity with other
unclassified substance dependence (OR = 10.817, 95% CI =
1.238–94.550, p = 0.031) were most strongly associated with
AUD in BD (Table 3).DISCUSSION
This study found that 74 (31%) of 238 BD patients had comorbid
AUD. AUD participants were more likely to be single men who
had harmed themselves more often, had their first depressive
episode younger, experienced irritability during their most severe
depressive episode, reported substance dependence additionally
on something other than alcohol, and reported PTSD.
Many international studies have reported high rates of
comorbidity between AUD and BD. Similar rates of BD with
comorbid AUD have been reported in recent epidemiological
surveys in Australian communities (27 and 32% respectively
reported by Mitchell et al. (5) and Morgan et al. (34).
Here, male BD patients had a 2.26 times greater risk of
comorbid AUD than female BD patients, which is consistent
with several other studies (7, 8, 12–14, 33, 35). A meta-analysis of
clinical studies found that being male was associated with double
the lifetime prevalence of AUDs in BD (44%), compared to being
female (22%) (35). As in the present study, male BD patients had
2–3 times greater risk of lifetime AUD. Frye et al. found that
more men with BD met the criteria for lifetime alcoholism in the
general population. However, compared to general population
rates, Frye et al. found women with BD (OR = 7.35) have a higher
risk of comorbid AUD than for men with BD (OR = 2.77) (11).
We found that those BD patients with comorbid AUD were
2.66 times more likely to be divorced, separated, or widowed. This
finding is consistent with results from the US National
Epidemiologic Survey on Alcohol and Related Conditions,
which reported that rates of substance abuse and dependence
were generally greater amongmen, native Americans, respondentsSeptember 2020 | Volume 11 | Article 570574
Xia et al. Bipolar and Alcohol Use Disorderaged 18 to 44 years, those of lower socioeconomic status, those
residing in the Western United States, and those who were never
married or were widowed, separated, or divorced (14). Here, levels
of educational attainment or income source (i.e., personal income
or government social support) did not differ between groups.
The prevalence of BD subgroups (particularly BD-I and BD-
II) did not differ between the two groups in this study, a finding
inconsistent with some previous reports. Several studies have
reported a higher prevalence of AUD in patients with BD-I
compared to BD-II disorder (Chengappa et al: 49.3 vs. 38.9%
(36), Frye et al: 41.1 vs. 25.0% (11), Regier et al: 46.2 vs. 39.2%
(37)). But the prevalence of AUDs was higher in BD-II disorder
than in BD-I (26.8 vs. 14.9%) in Simhandl’s research (8). It is
possible that this lack of difference may have been due to the
relatively low proportion of BD-II patients in this sample (only
31% had BD-II).
For those BD patients with comorbid AUD who had
attempted suicide, the number of reported self-harming events
was higher than those without AUD who had also attemptedFrontiers in Psychiatry | www.frontiersin.org 4suicide. Chen and Dilsaver reported that 25–60% of BD patients
had at least one suicide attempt (38). Cardoso et al. found that
BD patients with AUD were more likely to have attempted
suicide and a trend that the more severe the alcohol
comorbidity, the higher the number of suicide attempts (13). A
more recent Brazilian study has reported that more BD patients
with AUD had at least one suicide attempt and had also
attempted suicide more frequently (33). This finding is also
consistent with results from the US National Epidemiologic
Survey on Alcohol and Related Conditions (9).
There were more patients with AUD who reported irritability
in their most severe lifetime depressive episode. This is a novel
finding, which has not been previously reported. This
observation may be related to the common causal factors
related to the genetics of AUD and BD. And patients are
prone to heavier drinking when they are depressed. The
irritability is a common result of hangovers.
We did not find any differences in the age of first onset of
mood episodes, number of lifetime episodes, likelihood ofTABLE 1 | Logistic regression analysis of potential risk factors in sociodemographic and clinical features of bipolar patients after adjusting for age and gender.
Variables Without AUD (N = 164) With AUD (N = 74) OR (95% CI) P value
% %
Gender (male) 35.0 48.6 2.256 (1.238–4.111) 0.008**
Marital status
Married or de facto 52.2 32.4 2.657 (1.137–6.206) 0.024*
Separated, divorced, or widowed 15.5 21.1 1.785 (0.881–3.618) 0.108
Never married 32.3 46.5
Labor force status (employed) 47.8 63.4 1.788 (0.982–3.254) 0.057
Education for at least 10 years 89.3 88.2 0.713 (0.279–1.822) 0.479
Main source personal income
Self employed 44.7 54.9 1.307 (0.506–2.123) 0.922
Spouse or partner’s employment 22.6 12.7 0.672 (0.261–1.734) 0.411
Parental support, student loan 7.5 7.0 1.135 (0.332–3.883) 0.841
Social benefit 25.2 25.4
Born in Australia 77.8 70.6 0.701 (0.361–1.362) 0.701
Primary diagnosis
Bipolar I 71.3 63.4 0.442 (0.059–3.300) 0.426
Bipolar II 27.4 33.8 0.587 (0.076–4.536) 0.610
Bipolar disorder due to substance use or
general medical condition
0.0 1.4
Bipolar disorder NOS 1.2 1.4
Hurt oneself on purpose 46.2 46.4 0.945 (0.520–1.717) 0.853
Number of times patient hurt self on purpose in
patients who had attempted suicide
Once 18.1 7.2 3.719 (1.220– 0.021*
Two or more times 27.1 37.7 11.340)
Feeling irritable in a past major depressive episode 50.9 74.5 2.433 (1.128–5.249) 0.023*
Family history
Bipolar disorder 31.0 26.6 0.907 (0.458–1.795) 0.779
Unipolar disorder 56.8 62.5 1.103 (0.582–2.087) 0.764
Hospitalization for BD 69.5 56.5 0.632 (0.343–1.165) 0.141
Mean ± SD Mean ± SD
Age at enrolment 40.556 ± 13.205 36.446 ± 10.750 0.965 (0.940–0.990) 0.006**
Age for first depression episode 21.830 ± 11.075 18.060 ± 8.582 0.974 (0.936–1.013) 0.192
Age for first (hypo)mania episode 25.850 ± 11.210 23.090 ± 10.195 0.992 (0.956–1.029) 0.657
Age for first time to hurt oneself 26.440 ± 25.101 20.780 ± 10.643 0.972 (0.973–2.539) 0.313
Onset age of AUD NA 18.930 ± 12.655
Estimated drinks per day last year 1.990 ± 3.416 7.660 ± 5.628September 2020 | Volume 11 | Article*Value is statistically significant (p < 0.05) (in bold).
**Value is statistically significant (p < 0.01) (in bold).
NA, not applicable.570574
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group. This is not consistent with previous studies, which have
tended to show a worse prognosis in BD patients with AUD (8,
12, 13, 33, 39, 40). Those studies have reported that individuals
with comorbid BD and substance-use disorders have a more
severe course of illness, including earlier onset, more frequent
episodes, and more complications, including anxiety- and
stress-related disorders, aggressive behavior, legal problems,
and suicide (40). Compared to the present study, these studies
tend to have used longer data collection periods. It has been
reported that BD patients with AUD have more psychiatric
hospitalizations after adjusting for gender, race, employment
status, education level, and duration of illness (41). The study
from Simhandl et al. suggested that comorbid AUD had a
negative impact on bipolar I participants, increasing
depressive episodes (8). A recent study also confirmed the
role of the male gender, additional substance use disorder,Frontiers in Psychiatry | www.frontiersin.org 5and irritable and hyperthymic temperaments as predictors of
AUD in BD (12).
There were higher rates of rapid cycling in the AUD group,
which was not significant using a conservative approach of
controlling for age and gender. There were no significant
differences in the severity of cross-sectional symptoms. Other
groups have reported that BD patients with AUD have higher
rates of mixed or dysphoric mania, rapid cycling, increased
severity of manic and depressive symptoms (42, 43), and
higher levels of novelty seeking, suicidality, aggressiveness, and
impulsivity (14). Cardoso et al. found that BD patients with AUD
showed more depressive symptoms and poorer functioning, as
indicated by higher Hamilton Depression Rating Scale scores
and lower scores on the Global Assessment of Functioning Scale
(13). Other groups have also reported rapid cycling to be
associated with AUD in BD (33, 39, 44, 45). Cruz et al. found
that a greater percentage of BD patients with rapid cycling had a
history of AUD than those without rapid cycling (44). BD
patients with AUD were more likely to present with rapid
cycling in a Brazilian sample (33). These studies had larger
sample sizes than the present study, so may have been more
sensitive to detect small effects.
We found higher rates of comorbidity with PTSD, cannabis
dependence, and other substance dependence in those with
AUD. These findings are consistent with a number of prior
reports (7, 13, 33, 46–48). Nery et al. found that BD patients with
AUD had a significantly higher prevalence of comorbid
substance (non-alcohol) use disorders, PTSD, and anorexia
(33). More than 50% of patients with co-occurring BD andTABLE 2 | Logistic regression analysis of potential risk factors in comorbidities with substance abuse disorders and anxiety disorders of bipolar patients after adjusting
for age and gender.
Comorbid diseases Without AUD
(N = 164) (%)
With AUD
(N = 74) (%)
OR (95% CI) P value
Substance abuse disorders
Cannabis dependence 2.4 13.5 5.252 (1.556–17.720) 0.008**
Other unclassified substance dependence 0.6 10.8 18.900 (2.241–159.381) 0.007**
Opioid dependence 0.6 1.4 1.905 (0.108–33.670) 0.660
Opioid abuse 0.0 1.4 48,535,353.15 (0.000–) 0.995
Cannabis abuse 1.2 0.0 0.000 (0.000–) 0.997
Sedative dependence 4.3 9.5 12.532 (0.814–7.875) 0.109
Sedative abuse 1.2 2.7 3.208 (0.370–27.813) 0.290
Cocaine dependence 0.6 1.4 1.703 (0.102–28.356) 0.710
Amphetamine dependence 0.6 1.4 2.795 (0.151–51.681) 0.490
Hallucinogen abuse 0.0 1.4 10,730,842.03 (0.000–) 0.995
Anxiety disorders
PTSD 11.6 25.7 2.475 (1.195–5.128) 0.015*
OCD 6.7 12.2 1.607 (0.621–4.157) 0.328
Panic disorder without agoraphobia 4.9 9.5 2.006 (0.676–5.954) 0.210
Panic disorder with agoraphobia 3.7 2.7 0.788 (0.148–4.210) 0.781
Agoraphobia without panic disorder 4.3 1.4 0.350 (0.041–3.005) 0.338
Social phobia 17.1 25.7 1.519 (0.770–2.998) 0.228
Special phobia animal 4.3 6.8 1.604 (0.474–5.426) 0.447
Special phobia natural 3.7 2.7 0.686 (0.131–3.583) 0.655
Special phobia blood 2.4 5.4 1.980 (0.469–8.359) 0.352
Special phobia situation 4.3 2.7 0.562 (0.111–2.840) 0.486September 2020 | Volume 11 | Article*Value is statistically significant (p < 0.05) (in bold).
**Value is statistically significant (p < 0.01) (in bold).TABLE 3 | Multivariate logistic regression analysis of potential risk factors for
bipolar patients with alcohol use disorder (AUD).
Variables OR 95% CI P value
Male 2.086 1.094–3.979 0.026*
Age at enrollment 0.965 0.935–0.996 0.026*
Other unclassified substance dependence 10.817 1.238–94.550 0.031*
Cannabis dependence 3.596 0.960–13.478 0.058
PTSD 1.700 0.744–3.887 0.208
Separated, divorced, or widowed 2.245 0.922–5.466 0.075*Value is statistically significant (p < 0.05).570574
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(76.7%) or drug dependence disorder (60.0%) in the study
by Prisciandaro et al. Comorbid anxiety disorders were
prospectively associated with increased depressive symptoms
and alcohol use (48).
Here, multivariate logistic regression showed that male,
younger age, and with other unclassified substance dependence
(DSM-IV diagnosis code 304.90) were strongly related to AUD
with BD. Few other studies of AUD in BD have reported the
findings of multivariate logistic regression analyses. This finding
is partly consistent with results from one of the few other studies
(33). In this study, variables including male gender, younger age
at onset of the mood disorder, a lifetime substance (non-alcohol)
use disorder, lifetime PTSD diagnosis, history of lifetime suicide
attempts, and a family history of substance use disorders were
most strongly associated with a lifetime AUD diagnosis in BD
patients. Drinking and depression appeared to have a positive
relationship among men (49).
Limitations
First, the study features a relatively small sample size. More
participants will be recruited in a future study. Second, the study
was cross-sectional, so the findings can only demonstrate
associations rather than directional causality. Third, participants
were all recruited from a single clinic. The results of this study
cannot necessarily be extrapolated to people from other
geographical locations or other types of service. Fourth, the
present study did not determine whether BD manifested before
AUD or vice versa and the CIDI-AUTO’s measures of alcohol
intake is relatively crude. Some form of diary or quantity-frequency
measure would be preferable. Fifth, there was no comparison of BD
I versus BD II in the current analysis due to lack of data (or concern
of the lack of power in the subgroup analysis). Sixth, the ethnicity of
the participants was not investigated in this study, therefore it may
not be possible to extend the results to people from diverse ethnic
backgrounds. Seventh, data on medications was not gathered,
although medication can affect brain structure (50), behavior
(51), and substance abuse (52), which will be explored in the
future study.CONCLUSIONS
This study found that being male, younger, and having another
unclassified substance dependence were strongly related to AUD
in BD. In the BD clinic, younger single men who have self-
harmed more than once and are known to be polysubstance
users may be at higher risk of AUD. This knowledge could help
early identification and intervention.Frontiers in Psychiatry | www.frontiersin.org 6DATA AVAILABILITY STATEMENT
The original contributions presented in the study are included in
the article/Supplementary Materials; further inquiries can be
directed to the corresponding authors.ETHICS STATEMENT
The studies involving human participants were reviewed and
approved. This study was approved by the Human Research
Ethics Committee of University of New South Wales. All
procedures performed in studies involving human participants
were in accordance with the ethics standards of the institutional
and national research committee and with the 1964 Helsinki
Declaration and its later amendments or comparable ethics
standards. The patients/participants provided their written
informed consent to participate in this study.AUTHOR CONTRIBUTIONS
YX, DM, JH and PM conceived and designed research. YX and
DM collected data and conducted research. YX, DM, TP, JH and
PM analyzed and interpreted data. YX and DM wrote the initial
paper. TP, JH and PM revised the paper. JH had primary
responsibility for final content. All authors contributed to the
article and approved the submitted version.FUNDING
This research was supported by the National Natural Science
Foundation of China (No. 81501147) to YX and the National
Natural Science Foundation of China (No. 61773134) to DM.
The study was also supported by the Australian National Medical
and Health Research Council (Program Grant 1037196). The
authors declare that they have no financial relationship with the
organization that sponsored the research, and the funding body
was not involved in study design, data collection, analysis and
writing of the study. This research was also supported by the
National Key R&D Program of China (No. 2018YFC1314400,
2018YFC1314402) to JH.SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at: https://www.frontiersin.org/articles/10.3389/fpsyt.2020.
570574/full#supplementary-materialREFERENCES
1. Anderson IM, Haddad PM, Scott J. Bipolar disorder. BMJ (2012) 345:e8508.
doi: 10.1136/bmj.e8508
2. American Psychiatric Association.Diagnostic and statistical manual of mental
disorders (5th ed.). Arlington, VA (2013).3. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM,
Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum
disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry
(2007) 64:543–52. doi: 10.1001/archpsyc.64.5.543
4. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al.
Prevalence and Correlates of Bipolar Spectrum Disorder in the WorldSeptember 2020 | Volume 11 | Article 570574
Xia et al. Bipolar and Alcohol Use DisorderMental Health Survey Initiative. Arch Gen Psychiatry (2011) 68:241–51. doi:
10.1001/archgenpsychiatry.2011.12
5. Mitchell PB, Johnston AK, Frankland A, Slade T, Green MJ, Roberts G, et al.
Bipolar disorder in a national survey using the World Mental Health Version
of the Composite International Diagnostic Interview: the impact of differing
diagnostic algorithms. Acta Psychiatr Scandinav (2013) 127:381–93. doi:
10.1111/acps.12005
6. N.I.o. Health, Alcohol Use Disorder: A Comparison Between DSM—IV and
DSM–5. Rockville, MD, USA: NIH (2014).
7. Frye MA, Altshuler LL, Mcelroy SL, Suppes T, Keck PE, Denicoff K, et al.
Gender differences in prevalence, risk, and clinical correlates of alcoholism
comorbidity in bipolar disorder. Am J Psychiatry (2003) 160:883. doi:
10.1176/appi.ajp.160.5.883
8. Simhandl C. Prevalence and impact of comorbid alcohol use disorder in
bipolar disorder: A prospective follow-up study. Aust New Z J Psychiatry
(2015) 50:345. doi: 10.1177/0004867415585855
9. Oquendo MA, Currier D, Liu S, Hasin D, Grant B, Blanco C. Increased Risk
for Suicidal Behavior in comorbid Bipolar Disorder and Alcohol Use
Disorders. J Clin Psychiatry (2010) 71:902–9. doi: 10.4088/JCP.09m05198gry
10. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, et al.
Prevalence, Correlates, and Disability of Personality Disorders in the United
States: Results From the National Epidemiologic Survey on Alcohol and
Related Conditions. J Clin Psychiatry (2004) 65:948–58. doi: 10.4088/
JCP.v65n0711
11. Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence
rate and treatment considerations. Bipolar Disord (2010) 8:677–85. doi:
10.1111/j.1399-5618.2006.00370.x
12. Azorin JM, Perret LC, Fakra E, Tassy S, Simon N, Adida M, et al. Alcohol use
and bipolar disorders: Risk factors associated with their co-occurrence and
sequence of onsets. Drug Alcohol Depend (2017) 179:205–12. doi: 10.1016/
j.drugalcdep.2017.07.005
13. Cardoso BM, Kauer Sant’Anna M, Dias VV, Andreazza AC, Ceresér KM,
Kapczinski F. The impact of co-morbid alcohol use disorder in bipolar
patients. Alcohol (2008) 42:451–7. doi: 10.1016/j.alcohol.2008.05.003
14. Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates,
disability, and comorbidity of DSM-IV drug abuse and dependence in the
United States: results from the national epidemiologic survey on alcohol and
related conditions. Arch Gen Psychiatry (2007) 64:566–76. doi: 10.1001/
archpsyc.64.5.566
15. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar
Disord (2015) 3:181–8. doi: 10.1034/j.1399-5618.2001.30403.x
16. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective
disorder. J Nerv Ment Dis (1994) 182:349–52. doi: 10.1097/00005053-
199406000-00007
17. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and
of substance use disorders in bipolar I disorder. Bipolar Disord (2010) 10:67–
78. doi: 10.1111/j.1399-5618.2008.00461.x
18. Khalsa HM, Salvatore P, Hennen J, Baethge C, Tohen M, Baldessarini RJ.
Suicidal events and accidents in 216 first-episode bipolar I disorder patients:
predictive factors. J Affect Disord (2008) 106:179–84. doi: 10.1016/
j.jad.2007.05.027
19. Strakowski SM, Delbello MP, Fleck DE, Adler CM, Anthenelli RM, Keck PE,
et al. Effects of Co-occurring Cannabis Use Disorders on the Course of Bipolar
Disorder After a First Hospitalization for Mania. Arch Gen Psychiatry (2007)
64:57–64. doi: 10.1001/archpsyc.64.1.57
20. Weiss RD. Treating patients with bipolar disorder and substance dependence:
lessons learned. J Subst Abuse Treat (2004) 27:307–12. doi: 10.1016/
j.jsat.2004.10.001
21. Carrà G, Bartoli F, Crocamo C, Brady KT, Clerici M. Attempted suicide in
people with co-occurring bipolar and substance use disorders: systematic
review and meta-analysis. J Affect Disord (2014) 167:125–35. doi: 10.1016/
j.jad.2014.05.066
22. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on
heroin and cocaine dependence. Am J Psychiatry (1985) 142:1259–64. doi:
10.1176/ajp.142.11.1259
23. Weiss RD, Kolodziej M, GriffinML, Najavits LM, Jacobson LM, Greenfield SF.
Substance use and perceived symptom improvement among patients withFrontiers in Psychiatry | www.frontiersin.org 7bipolar disorder and substance dependence. J Affect Disord (2004) 79:279–83.
doi: 10.1016/S0165-0327(02)00454-8
24. Carmiol N, Peralta JM, Almasy L, Contreras J, Pacheco A, Escamilla MA, et al.
Shared genetic factors influence risk for bipolar disorder and alcohol use
disorders. Eur Psychiatry (2014) 29:282–7. doi: 10.1016/j.eurpsy.2013.10.001
25. Kessler RC, Merikangas KR, Wang PS. Prevalence, Comorbidity, and Service
Utilization for Mood Disorders in the United States at the Beginning of the
Twenty-first Century. Annu Rev Clin Psychol (2007) 3:137–58. doi: 10.1146/
annurev.clinpsy.3.022806.091444
26. Algelban KS, Alamri HS, Mostafa OA. Prevalence of Depression, Anxiety and
Stress as Measured by the Depression, Anxiety, and Stress Scale (DASS-42)
among Secondary School Girls in Abha, Saudi Arabia. Sultan Qaboos Univ
Med J (2009) 9:140–7.
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to
change. Br J Psychiatry (1979) 134:382–9. doi: 10.1192/bjp.134.4.382
28. Berk M, Malhi GS, Cahill C, Carman AC, Hadzi-Pavlovic D, Hawkins MT,
et al. The Bipolar Depression Rating Scale (BDRS): its development, validation
and utility. Bipolar Disord (2010) 9:571–9. doi: 10.1111/j.1399-5618.
2007.00536.x
29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania:
reliability, validity and sensitivity. Br J Psychiatry (1978) 133:429–35. doi:
10.1192/bjp.133.5.429
30. Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development,
reliability and acceptability of a new version of the DSM-IV Social and
Occupational Functioning Assessment Scale (SOFAS) to assess routine social
functioning. Acta Psychiatr Scand (2010) 101:323–9. doi: 10.1111/j.1600-
0447.2000.tb10933.x
31. Parker G, Hadzi-Pavlovic D, Boyce P, Wilhelm K, Brodaty H, Mitchell P, et al.
Classifying depression by mental state signs. Br J Psychiatry (1990) 157:55–65.
doi: 10.1192/bjp.157.1.55
32. Peters L, Andrews G. Procedural validity of the computerized version of the
Composite International Diagnostic Interview (CIDI-Auto) in the anxiety
disorders. Psychol Med (1995) 25:1269–80. doi: 10.1017/S0033291700033237
33. Nery FG, Miranda-Scippa A, Nery-Fernandes F, Kapczinski F, Lafer B.
Prevalence and clinical correlates of alcohol use disorders among bipolar
disorder patients: Results from the Brazilian Bipolar Research Network.
Compr Psychiatry (2014) 55:1116–21. doi: 10.1016/j.comppsych.2014.02.006
34. Morgan VA, Mitchell PB, Jablensky AV. The epidemiology of bipolar
disorder: sociodemographic, disability and service utilization data from the
Australian National Study of Low Prevalence (Psychotic) Disorders. Bipolar
Disord (2015) 7:326–37. doi: 10.1111/j.1399-5618.2005.00229.x
35. Craddock DFN, Van de Bree M. Alcohol misuse in bipolar disorder. A
systematic review and meta-analysis of comorbidity rates. Eur Psychiatry
(2014) 29:117–24. doi: 10.1016/j.eurpsy.2013.07.004
36. Chengappa KR, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of
substance or alcohol abuse and dependence among subjects with bipolar I
and II disorders in a voluntary registry. Bipolar Disord (2015) 2:191–5. doi:
10.1034/j.1399-5618.2000.020306.x
37. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al.
Comorbidity of mental disorders with alcohol and other drug abuse.
Results from the Epidemiologic Catchment Area (ECA) Study. JAMA
(1990) 264:2511–8. doi: 10.1001/jama.264.19.2511
38. Chen YW, Dilsaver SC. Lifetime rates of suicide attempts among subjects with
bipolar and unipolar disorders relative to subjects with other axis I disorders.
Biol Psychiatry (1996) 39:896–9. doi: 10.1016/0006-3223(95)00295-2
39. Rakofsky JJ,DunlopBW.Doalcoholusedisordersdestabilize the courseof bipolar
disorder? J Affect Disord (2013) 145:1–10. doi: 10.1016/j.jad.2012.06.012
40. Swann AC. The strong relationship between bipolar and substance-use
disorder. Ann N Y Acad Sci (2010) 1187:276–93. doi: 10.1111/j.1749-
6632.2009.05146.x
41. Yee HA, Loh HS, Ng CG. The prevalence and correlates of alcohol use
disorder amongst bipolar patients in a hospital setting, Malaysia. Int J
Psychiatry Clin Pract (2013) 17:292–7. doi: 10.3109/13651501.2012.752012
42. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE.
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in
the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005)
62:593–602. doi: 10.1001/archpsyc.62.6.593September 2020 | Volume 11 | Article 570574
Xia et al. Bipolar and Alcohol Use Disorder43. O’Brien CP, Charney DS, Lewis L, Cornish JW, Post RM, Woody GE, et al.
Priority actions to improve the care of persons with co-occurring substance
abuse and other mental disorders: a call to action. Biol Psychiatry (2004)
56:703–13. doi: 10.1016/j.biopsych.2004.10.002
44. Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J. Rapid-cycling
bipolar I disorder: course and treatment outcome of a large sample across
Europe. J Psychiatr Res (2008) 42:1068–75. doi: 10.1016/j.jpsychires.
2007.12.004
45. Ostacher MJ, Perlis RH, Nierenberg AA, Calabrese J, Stange JP, Salloum I,
et al. Impact of substance use disorders on recovery from episodes of
depression in bipolar disorder patients: prospective data from the
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-
BD). Am J Psychiatry (2010) 167:289–97. doi: 10.1176/appi.ajp.2009.09020299
46. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC.
Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with
other psychiatric disorders in the National Comorbidity Survey. Arch Gen
Psychiatry (1997) 54:313–21. doi: 10.1001/archpsyc.1997.01830160031005
47. Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD.
Anxiety disorders among patients with co-occurring bipolar and substance
use disorders. Drug Alcohol Depend (2005) 80:251–7. doi: 10.1016/
j.drugalcdep.2005.04.003
48. Prisciandaro JJ, Brown DG, Brady KT, Tolliver BK. Comorbid anxiety
disorders and baseline medication regimens predict clinical outcomes in
individuals with co-occurring bipolar disorder and alcohol dependence:
Results of a randomized controlled trial. Psychiatry Res (2011) 188:361–5.
doi: 10.1016/j.psychres.2011.04.030Frontiers in Psychiatry | www.frontiersin.org 849. Walther A, Rice T, Kufert Y, Ehlert U. Neuroendocrinology of a male-specific
pattern for depression linked to alcohol use disorder and suicidal behavior.
Front Psychiatry (2017) 7:206. doi: 10.3389/fpsyt.2016.00206
50. Sani G, Simonetti A, Janiri D, Banaj N, Ambrosi E, De Rossi P, et al.
Association between duration of lithium exposure and hippocampus/
amygdala volumes in type I bipolar disorder. J Affect Disord (2018)
232:341–8. doi: 10.1016/j.jad.2018.02.042
51. Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD. Pattern of
response to divalproex, lithium, or placebo in four naturalistic subtypes of
mania. Neuropsychopharmacology (2002) 26:530–6. doi: 10.1016/S0893-133X
(01)00390-6
52. Kitanaka N, Hall FS, Uhl GR, Kitanaka J. Lithium pharmacology and a
potential role of lithium on methamphetamine abuse and dependence. Curr
Drug Res Rev Formerly: Curr Drug Abuse Rev (2019) 11:85–91. doi: 10.2174/
2589977511666190620141824
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Xia, Ma, Perich, Hu and Mitchell. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice. No
use, distribution or reproduction is permitted which does not comply with these terms.September 2020 | Volume 11 | Article 570574
